Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Equine veterinary research gets £1.6 million boost
HBLB awarded research and education grants

The Horserace Betting Levy Board (HBLB) has awarded £1.6 million in equine veterinary research and education grants for 2013, an increase of over 30 per cent on this year's allocation.

Nine new research projects will be supported in disciplines that reflect the HBLB's research priorities. The prevention of infectious disease remains a key priority and one in which the HLB has invested over the years. Previous funding towards effective vaccines for 'rattles' and strangles will be built upon, as will the modelling of the potential effects of African Horse Sickness, in the event of it spreading to Britain.

The creation of a rapid diagnostic test for West Nile disease will also receive funding, and research will also commence towards improved vaccines and novel drugs to protect the thoroughbred breeding industry from equine herpes virus, which can cause abortion, neonatal death and neurological disease.

Professor Willie Donachie, Chair of the HBLB's Veterinary Advisory Committee, said: "We are delighted that the Board has been able to commit £1.6m in 2012 and continue with its long-standing and effective investment in key areas such as infectious disease, racehorse safety and musculoskeletal injury. The grants that have been awarded support a full programme of scientific research and education that will make relevant and useful contributions to racehorse health for owners, breeders, trainers and their veterinary advisers."



Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'